We demonstrate the value of using a cocktail of protein kinase inhibitors against a form of kidney cancer. For this, they assessed the impact of combinations of molecules on the viability of kidney cancer cells grown as spheroids, or organ cultures of tumors. The synergistic benefit of two molecules allowed to file a patent.